MFBTD
TEVA icon

MB Financial Bank - Trust Department’s Teva Pharmaceuticals TEVA Stock Holding History

MB Financial Bank - Trust Department’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-4,000
Closed -$68K – 490
2018
Q1 		$68K Sell
4,000
-5,000
-56% -$97.6K 0.01% 207
2017
Q4 		$171K Sell
9,000
-4,000
-31% -$60.2K 0.02% 158
2017
Q3 		$229K Hold
13,000
– – 0.02% 140
2017
Q2 		$432K Buy
13,000
+3,000
+30% +$92.9K 0.05% 106
2017
Q1 		$321K Hold
10,000
– – 0.04% 120
2016
Q4 		$363K Hold
10,000
– – 0.04% 118
2016
Q3 		$460K Hold
10,000
– – 0.05% 94
2016
Q2 		$502K Hold
10,000
– – 0.06% 91
2016
Q1 		$535K Sell
10,000
-87
-0.9% -$5.11K 0.06% 86
2015
Q4 		$662K Sell
10,087
-282
-3% -$17.4K 0.08% 86
2015
Q3 		$585K Buy
10,369
+82
+0.8% +$5.32K 0.07% 92
2015
Q2 		$608K Buy
10,287
+87
+0.9% +$5.37K 0.07% 86
2015
Q1 		$635K Hold
10,200
– – 0.08% 88
2014
Q4 		$587K Sell
10,200
-10,200
-50% -$568K 0.07% 99
2014
Q3 		$1.08M Buy
20,400
+10,200
+100% +$540K 0.07% 110
2014
Q2 		$535K Hold
10,200
– – 0.07% 113
2014
Q1 		$539K Buy
10,200
+2,000
+24% +$92.4K 0.07% 102
2013
Q4 		$329K Buy
+8,200
New +$323K 0.05% 128
2013
Q3 		– Sell
-46
Closed -$2K – 397
2013
Q2 		$2K Buy
+46
New +$1.79K ﹤0.01% 359

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
NC
Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return

MB Financial Bank - Trust Department's TEVA Position: Q2 2018 in Review

MB Financial Bank - Trust Department sold out of Teva Pharmaceuticals (TEVA) in Q2 2018, closing a stake of 4,000 shares — an estimated $68K sold.

MB Financial Bank - Trust Department first reported a position in TEVA in Q2 2013 and held it in 19 quarters. The position peaked at $1.08M in Q3 2014. 540 funds tracked by Wall St. Rank hold TEVA as of Q2 2018.

  • MB Financial Bank - Trust Department reported no remaining Teva Pharmaceuticals position as of Q2 2018 after selling out during the quarter.
  • MB Financial Bank - Trust Department sold 4,000 Teva Pharmaceuticals shares in Q2 2018, an estimated $68K.
  • MB Financial Bank - Trust Department first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 19 quarters.
  • MB Financial Bank - Trust Department's Teva Pharmaceuticals position peaked at $1.08M in Q3 2014.
  • 540 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2018.

Based on MB Financial Bank - Trust Department's 13F filing for Q2 2018, filed 12 Jul 2018.